Four Cube Pharma Products Added to National Essential Medicines List

财中社··Read original
3▲1 ▼0Impact / 5
Summary · why it matters

Cube Pharma announced that four of its products have been newly included in the National Essential Medicines List, 2026 edition. With this addition, the company and its subsidiaries now have a total of 15 products on the list. In the first quarter of 2026, Cube Pharma reported revenue of 357 million yuan and net profit attributable to the parent company of 35.29 million yuan.

Impact on assets 1

Others▲ · 1 stocks
© 2026 MarketIVNews